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Exposure of C6 glioma cells to 1 PM isoprolerenol leads to fast desensitization of the B-adrenergic rcceptor/adenylyl cyclase system and transient 
receptor sequestration. It also triggers a very rapid and transient ranslocation to the plasma membrane ofa-adrcnergic refeptor kinasc (BARK), 
a specific ytoplasmic kinasc that phosphorylatcs only the agonist-occupied form of several G protein-coupled receptnrs.&fARK-mediated r ceptor 
phosphorylation appears to bc a suitable rncchanism for the rapid regulation of adrencrgic receptor function in the nervous tissue. 
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1. INTRODUCTION 
Desensitization is a general cellular process in which 
response to a continuous or repeated stimulus attenu- 
ates with time. The /?-adrenergic receptor @AR)lade- 
nylyl cyclase system has been widely used as a model for 
such a phenomenon [I 21. The molecular mechanisms 
underlying desensitization of BARS seem to involve 
both internalization of plasma membrane receptors and 
functional uncoupling of the receptor from the signal 
transducing protein, G’s, Such uncoupling can be trig- 
gered by BAR phosphorylation by protein kinase A 
(PKA) or by /%adrenergic receptor kinase (BARK). 
BARK is a cytoplasmic kinase that specifically phos- 
phorylates the agonist-occupied form of the j?AR and 
other related G protein-coupled receptors [1,3,4], thus 
promoting the binding to the receptor of another pro- 
tein, p-arrestin, which inhibits its coupling with G’s and 
adenylyl cyclase [S]. 
Several studies performed with &adrenergic recep 
tors mutated at the presumed sites of phosphorylation 
by PKA or PARK [B], permeabilized A431 carcinoma 
cells treated with inhibitors of these kinases [7-9] and 
kin- S49 lymphoma cells [lo], have suggested that 
PARK-mediated receptor phosphorylation and desensi- 
tization requires relatively high agonist concentrations 
in the external medium. Thus, it has been proposed that 
the role of this kinase would be specially important in 
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the nervous tissue, where neurons and glial cells are 
exposed to high and rapidly changing concentrations of
cathecholamines released at the synapses [S]. In fact, the 
expression of BARK is higher in the brain and highly 
innervated tissues [ll]. However, there is little knowl- 
edge about the mechanisms and kinetics of BARK 
translocation in nervous cells. In this report, we show 
that when C6 glioma cells are challenged with Bag- 
onists, a strikingly rapid and transient process of 
translocation of BARK activity takes place within the 
same time-frame of BAR desensitization and intemali- 
zation. 
2. MATERIALS AND METHODS 
Rat C6 glioma cells were grown as a monolayer on Falcon plastx 
dishes in Dulbecco’s modified Eagle’s medium (DMEM) with 10% 
horse strum and 2.5% fetal calf serum at 37°C in a humidified at- 
mosphcrc of 7% COz. Confluent cells were gently detached from t;lc 
dish surface, ccntrifugcd at 8M) x g for 3 min nnd resuspcndcd in
DMEM supplemented with 20 mM HEPES, pH 7.4, and I mM ascor- 
bic acid to a density of 3 x 106cells/ml. Aliquots of the suspnsion were 
incubated for l-10 min in the absence or presence of I PM (-)iso- 
protcrenol (Sigma). The incubations were slopped by diluting with 
ice-cold DMEM, 20 mM HEPES, and centrifugntion (SW xg, 4min). 
The cells were lyscd in 5 mM Tris-HCI, pH 7.4,2 mM EDTA, 3 mM 
MgCL, 1 mM phenylmethylsulfonil fluoride, 20 y@ml bcnzamidine 
and 20 p&ml leupeplin (ccl! lysis but&) using a pass homogenizer. 
Unbroken cells and nuclei were discarded after ccntrifugation at 800 
xg for 5 min, and crude plasma membrane and cytoplasmic fractions 
obtained by CentrifuBation at 12,000 x g for 30 min. These fractions 
were used for BAR binding or kinasc activity assays (set below). For 
adenylyl cyclasc assays, cell aliquots were incubated as above except 
that the CAMP phosphodicslerase inhibitor. isobutylmethylxanthine, 
was included (200 PM). After treatment, cells wcrc lyscd and cytoplas- 
miccAMP quantified by radioimmunoassay (Amcrsham) as dcscribcd 
t121. 
Binding oi the PAR &and i’ti]CGP-i2t7i (Amrrsila~d) to plasma 
membranes resuspended in cell lysis buflcr was prformcd essentially 
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Fig, I. (A) Rate of Sadrcncrgic agonists-stimulated a enylyl cyclase 
activity in whole C6 rat glioma cells incubated with I ,uM isoprorcrc. 
nol for the indicated periods of time. The results are means I S.E,M, 
of 3-4 independent experiments with triplicate CAMP determinations. 
(B)Changes inp-adrcnergic receptor number in the plasma membrane 
ofC6 glioma ccl!; stimulated with IBM isoproterenol for the indicated 
periods of time. Binding of [‘H]CGP- I21 77 was performed as detailed 
in section 2. The data are expressed as a percentage of the number of 
receptors present in the plasma membrane of cells not exposed to 
isoproterenol (73 f 8 fmol per mg of protein). Results are means + 
S.E.M. of 3-5 independent experiments. 
as reported [13]. Radiolipnd concentration was 2 nM and nonaspe- 
cific binding was determined in the presence of 50 AM propanolol. 
Since~ARK has been shown to specifically phosphorylate rhodop 
sin in an agonist-dependent fashion [14], BARK activities were as- 
scsscd by utilizing urea-treated purified rod outer segments as sub= 
strate. This method has been previously used to determine BARK 
activity in cellular fractions and in BARK purification studies 
[4,15.16]. Briefly, purified rod outer segments (devoid of endogenous 
rhodopsin kinase activity), containing 300-500 pmol of rhodopsin, 
were incubated for 20 min at 30°C in the presence of light in a medium 
containing 25 mM Tris-HCI. pH 7.5.6 mM ML$I~, 2 mM EDTA. 4.5 
mM NaF, 60 PM [gamma-“P]ATP (2-3 cpmfmol) and soluble ex- 
tracts from cells pretreated in different conditions. Reactions were 
stopped by diluting IO-fold with ice-cold cell lysis buffer and centrifug- 
Fig. 2. (A) Presence of BARK activity in soluble (lanes l-2) and 
particulate (lanes 3-4) fractions ofC6 glioma cells as demonstrated by 
lighl-dependent rhodopsin phosphorylation, Cell extracts were incu- 
bated with rhodopsin as detailed in section 2 either in the presence 
(lanes I and 3) or absence (lanes 2 and 4) of light, followed by SDS- 
PAGE and autoradiography in order to detect opsin phosphorylation. 
(B) Extraction of membrane-associated BARK activity by different 
methods. Membranes were treated as detailed in section 2 in the 
presence of Triton X-100 0,146 (lane l), 200 mM NaCl (lane 2) or 
subjected to repeated freeze-thawing (lane 3). Extracted proteins were 
assayed for PARK activity as above. The resulting rhodopsin 
phosporylaGon is shown. 
ing al 12,000 x g for I5 min. The resultant pellets were resuspended 
in sodium dodecyl sulfate buffer and electrophoresed as described [14]. 
After autoradiography of the gels, rhodopsin bands were excised and 
radioactivity counted as reported [4] to compare the kinase activity in 
different preparations. For determiningBARK activity in membrane 
frucLons, it first had to be extracted. Membranes resuspended in cell 
lysis buffer were treated for 15 min at 4°C either with 200 mM NaCl 
or Triton X-100 0.1% or subjccled to three cycles of freeze-thawing 
(see section 3). After treatments, membranes were pelleted and the 
supernatant containing the extracted proteins assayed forpARK ac- 
tivily as described above. 
3. RESULTS AND DISCUSSION 
Fig. 1 A shows that incubation of Cl glioma cells with 
1 PM isoproterenol for increasing periods of time re- 
sults in a marked decrease in the rate of CAMP synthesis 
stimulated by this b-adrenergic agonist, i.e. in func- 
tional uncoupling of the ,8ARladenylyl cyclase system, 
Isoproterenol also induces a rapid decrease in the num- 
ber of adrcncrgic rcccptors in the plasma membrane. 
Fig. lI3 indicates that after 2 min of exposure to this 
drug, =60% of the BAR binding sites present in non- 
62 
Volume 302, number 1 FEBS LETTERS May 1992 
A 
100 Tim0 Cmln) 0 1 2 0 10 
2 4 6 8 10 
Time (min) 
2 4 6 8 10 
Time lminl 
Fig. 3. Agonist-promoted changes in the subcellular distribution of BARK activity. After stimulation with 1 PM isoproterenol for the times 
indicated, cytaplasmic and membrane fractions were obtained from C6 glioma cells and assayed for BARK activity as described in section 2. The 
results arc expressed as a pcrccntagc of BARK specific activities in non-stimulated control cells (specific activities of 1.8 f 0.4 and 7,6 + 0.4 pmol 
per min per mg of protein for the soluble and membrane fractions, respectively). Data arc means t S.E.M. of the number of indcpcndcnt experiments 
indicated in parentheses, Insets, autoradiograms showing patterns ofBARK activity during agonist treatment in a reprcscntarive experiment. 
treated cells have been sequestered away from the 
plasma membrane. These results are indicative of an 
homologous desensitization process, in agreement with 
previously reported data [ 13,17,18]. Receptor disap 
pearance reflects its transient redistribution to an inter- 
nal vesicle fraction and is reversed once the stimulus is 
removed ([ 131 and data not shown). 
We next sought to establish whether BARK was im- 
plicated in the mechanism of desensitization, Fig. 2A 
shows that PARK activity is present in both soluble and 
particulate fractions of this glial cell line, as demon- 
strated by light-dependent phosphorylation of rhodop- 
sin. Membrane-associated activity had to be extracted 
prior to the rhodopsin assay. Since the BARK sequence 
does not include putative transmembranc domains, and 
its proposed mechanism of action suggests a transient, 
peripheral association with the plasma membrane, we 
screened several mild methods of extraction. Fig. 2B 
indicates that the removal of BARK activity is best 
attained after treatment with 200 mM NaCI; this 
method was thus used throughout he experiments, 
Activation of C6 glioma cells /?ARs with isoprotere- 
no1 promoteTX a very rapid change in the subcellular 
distribution ofBARK. Fig. 3 displays the time-course 
of the kinase activity in cytoplasm (A) and plasma mem- 
brane (B) fractions. A decrease in cytoplasmic BARK 
is clearly detected within 1 min of exposure to isoproter- 
enol and is maximal by 2 min of treatment, followed by 
a gradual return to control values. Conversely, mem- 
brane-associated BARK rapidly increases, reaches a 
peak by 2 min and declines thereafter. Interestingly, 
these changes take place within the same time-frame cf 
,8AR homologous desensitization. Although a detailed 
kinetic study has not been attempted, BARK transloca- 
tion is parallel to BAR sequestration and slightly pre- 
cedes the detection ofpAR/adenylyl cyclase uncoupling. 
The precise relationships between these processes are 
still a matter of controversy [6,8,9] and remain to be 
elucidated. However, such a close temporal relationship 
strongly suggests a role for DARK-induced receptor 
phosphorylation in BAR desensitization i  C6 glioma 
cells. It is worth noting that these cells express both&- 
and &adrenergic receptors in a 2: I ratio [ 191. Given the 
differences in putative BARK phosphorylation sites be- 
tween jJ,- an.d &receptors in several species (discussed 
in [19]), it would be of interest to determine if both 
receptor subtypes are regulated by the same mechanism 
and at the same rate. 
Transient translocation of BARK activity has been 
previously reported in DDT I -MF2 hamster smooth 
muscle cells and S49 lymphoma cells in response to 
/3-adrenergic, prostaglandin El and somatostatin ag- 
onists 14,201. In these experiments, the time-course of 
kinase tran.slocation was significantly slower than that 
observed in C6 glioma cells. On the other hand. our 
results tie in nicely with the rapidity ofpARK-induced 
receptor phosphorylation and desensitization (half- 
maximai at =20 s) recently detected in pc-rmeabihzed 
A431 epidermoid carcinoma cells [9]. Resides expri- 
mental differences, everal factors may affect the extent 
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and rate of BARK translocation and j?AR desensitiza- 
tion in dii’krnt cells and tissues, including density of 
receptors per cell, the expression levels and isoforms of 
the kinase, cell shape and subcellular location ofBARK 
under control conditions. The rapid translocation of 
BARK activity described in C6 glioma cells is consistent 
with its proposed key role in the rapid regulation of 
adrenergic receptor function in the nervous tissue [6,9], 
where neurons and glial cells are subjected to rapidly 
changing messenger environments. Finally, the experi- 
mental system reported herein could be of interest for 
investigating in more detail BAR desensitization mecha- 
nisms, as well as for testing the ability of agonists other 
than I-adrenergic ones in promoting BARK transloca- 
tion in different cultured cells. 
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